🔗 Permalink

Inventor profile of:

Michael J. Gerber

City:

Denver, Colorado

Country:

United States

Published Applications:

Last publication date:

2017-03-23

Top Assignees for applications by Michael J. Gerber

The entities that hold a legal rights for patent applications filed by inventor Gerber Michael J.:

GILEAD COLORADO, INC. 4 Westminster, CO United States
Peak Biosciences Inc. 3 Fort Collins, CO United States
AbbVie Deutschland GmbH & Co. KG 3 Wiesbaden, Germany
AbbVie Deutschland GmbH & Co. KG 2 Wiesbaden, Germany
Gilead Sciences, Inc. 1 Foster City, CA United States
PEAK BIOSCIENCE, INC. 1 FORT COLLINS, CO United States
Gilead Colorado, Inc. 1 Westminster, Colombia

Recent patent applications by Gerber Michael J.

Michael J. Gerber from Denver, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2017-03-23

US20170079978A1

Human necessities

THERAPY FOR COMPLICATIONS OF DIABETES

#2 | 2015-02-19

US20150051234A1

Human necessities

Therapy for complications of diabetes

#3 | 2014-10-02

US20140296244A1

Human necessities

Method for treating a pulmonary hypertension condition

#4 | 2014-03-13

US20140073574A1

Human necessities

Therapy for complications of diabetes

#5 | 2013-07-11

US20130178424A1

Human necessities

Therapy for complications of diabetes

#6 | 2013-05-09

US20130116257A1

Human necessities

METHOD FOR TREATING A PULMONARY HYPERTENSION CONDITION

#7 | 2011-10-06

US20110245253A1

Human necessities

Method for treating a pulmonary hypertension condition

#8 | 2011-06-09

US20110135569A1

Human necessities

METHOD FOR THERAPEUTIC ADMINISTRATION OF RADIONUCLEOSIDES

#9 | 2010-09-16

US20100233081A1

Human necessities

Methods of treatment of androgenic steroidal hormone dependent cancer with auger electron-emitting nucleoside analogs

#10 | 2010-09-02

US20100222668A1

Human necessities

Guidance and implantation of catheters

#11 | 2010-06-17

US20100152217A1

Human necessities

METHOD FOR TREATING A PULMONARY HYPERTENSION CONDITION

#12 | 2009-09-03

US20090221549A1

Human necessities

ANTIHYPERTENSIVE THERAPY

#13 | 2009-02-26

US20090054473A1

Human necessities

THERAPY FOR COMPLICATIONS OF DIABETES

#14 | 2008-06-19

US20080145433A1

Human necessities

DARUSENTAN ORAL DOSAGE FORM

#15 | 2008-06-12

US20080139593A1

Human necessities

METHOD FOR TREATING A PULMONARY HYPERTENSION CONDITION

#16 | 2007-08-23

US20070196510A1

Human necessities

Method for treating resistant hypertension

#17 | 2006-12-28

US20060292213A1

Human necessities

Enoximone formulations and their use in the treatment of PDE-III mediated diseases

#18 | 2006-02-09

US20060030611A1

Chemistry; metallurgy

Enoximone sulfoxide enantiomers and their use in the treatment of PDE-III mediated diseases

#19 | 2006-02-02

US20060025463A1

Chemistry; metallurgy

Enoximone sulfoxide enantiomers and their use in the treatment of PDE-III mediated diseases

InventorID:

236308 ⎘